Pathogenic Role of Cytokines and Effect of Their Inhibition in Psoriasis | IntechOpen
Mechanism of Action Matters: A Review of New and Emerging Biologics - Practical Dermatology
Recent advances in understanding psoriasis | F1000Research
New insights of T cells in the pathogenesis of psoriasis | Cellular & Molecular Immunology
Psoriasis pathogenesis and the development of novel targeted immune therapies - Journal of Allergy and Clinical Immunology
Schematic presenting the mechanism of disease relapse following... | Download Scientific Diagram
New drugs and treatment targets in psoriasis. | Semantic Scholar
Mechanism of Action | ILUMYA® (tildrakizumab-asmn) HCP
Medicinal Plants to Calm and Treat Psoriasis Disease | IntechOpen
The Pathogenesis and Genetics of Psoriasis | Actas Dermo-Sifiliográficas
Psoriasis pathogenesis and the development of novel targeted immune therapies - Journal of Allergy and Clinical Immunology
Psoriasis | NEJM
Psoriasis - The Lancet
Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor–modulating agent - Journal of the American Academy of Dermatology
Frontiers | Adaptive and Innate Immunity in Psoriasis and Other Inflammatory Disorders | Immunology
Psoriasis - Wikipedia
Mechanisms of psoriasis - ScienceDirect
STELARA® (ustekinumab) Mechanism of Action: Plaque Psoriasis
JCM | Free Full-Text | Molecular Pathogenesis of Psoriasis and Biomarkers Reflecting Disease Activity | HTML
Psoriasis | NEJM
Resolution of plaque-type psoriasis: what is left behind (and reinitiates the disease) | SpringerLink
The pathogenesis of psoriatic arthritis - The Lancet
The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses: Trends in Immunology
Resolution of plaque-type psoriasis: what is left behind (and reinitiates the disease) | SpringerLink
